Physician profile
Eric Giza
NPI 1811987571
$3,559,813.22
in general payments reported to CMS, 2019-2025
54 companies · $579K in 2025
The $579K reported for 2025 was more than what 99% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $526K · 2020: $410K · 2021: $580K · 2022: $455K · 2023: $527K · 2024: $482K · 2025: $579K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.0M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $316K · Consulting Fee: $179K · Travel and Lodging: $58K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,022,727.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $315,738.06 |
| Consulting Fee | $178,835.03 |
| Travel and Lodging | $57,704.73 |
| Food and Beverage | $13,448.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,129,510.64 | 2019-2025 | Arthrex, Distal Extremities Implants Foot & Ankle Ttc Nail, Distal Extremities Implants Foot & Ankle Metal Compression Screws |
| Zimmer Biomet Holdings, INC. | $153,686.14 | 2019-2025 | Accuport Cannula, Activbraid |
| Medshape, INC. | $150,056.76 | 2019-2024 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Restor3d, INC. | $25,234.69 | 2022-2025 | |
| Alafair Biosciences, INC. | $17,098.06 | 2020-2025 | Versawrap |
| Evolution Surgical, INC | $15,978.68 | 2019-2025 | |
| Ipsen Bioscience INC. | $13,947.18 | 2019 | |
| Sequoia Surgical, INC. | $13,604.87 | 2019-2022 | |
| Amniox Medical, INC. | $11,792.67 | 2020 | |
| Heron Therapeutics, INC. | $5,014.32 | 2021-2022 | |
| Biotissue Holdings INC. | $4,470.82 | 2020-2025 | |
| In2bones USA, LLC | $3,988.64 | 2019-2022 | |
| Linvatec Corporation | $2,319.73 | 2023-2025 | Allograft Tissue, Alloaid, Biobrace 23mm |
| Kairos Surgical INC | $2,228.60 | 2021 | |
| Bone Support INC. | $1,868.15 | 2021-2025 | Ceramentbone Void Filler, Cerament G |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $1,360.66 | 2025 | |
| Cornerstone Medical Associates, INC. | $1,212.00 | 2022 | |
| Kuros Biosciences USA, INC | $1,052.31 | 2025 | Magnetos |
| Stryker Corporation | $1,026.77 | 2019-2025 | Infinity Adaptis, Hoffmann, Incompass Total Ankle System |
| Vericel Corporation | $566.65 | 2022-2025 | Maci |
| Acell, INC. | $420.89 | 2019-2020 | |
| Exactech, INC. | $369.05 | 2020-2024 | |
| Steelhead Surgical INC | $275.96 | 2019-2024 | |
| Smith+Nephew, INC. | $237.39 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Pico |
| Dilon Technologies, INC. | $228.99 | 2025 | Hemoblast Bellows |
| Embody, INC. | $186.19 | 2021-2022 | |
| Integra Lifesciences Corporation | $176.65 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $146.02 | 2020-2023 | |
| Encore Medical, Lp | $145.91 | 2021 | |
| Bioventus LLC | $140.83 | 2025 | Exogen Ultrasound Bone Healing System |
| Coastal Medical Technologies LLC | $133.94 | 2025 | |
| Orthofix Medical, INC. | $132.66 | 2024 | Physio-Stim |
| Medline Industries Lp | $117.42 | 2024 | |
| Saxum Surgical, INC. | $91.38 | 2023 | |
| Novastep INC. | $89.83 | 2022 | |
| Smoky Mountain Surgical LLC | $77.29 | 2025 | |
| Acera Surgical, INC. | $71.07 | 2024 | Restrata Wound Matrix |
| Ethicon US, LLC | $67.50 | 2021 | |
| Ossio INC | $65.43 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $64.87 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $62.31 | 2024 | |
| Baudax Bio INC. | $57.59 | 2021 | |
| Abanza INC. | $52.82 | 2025 | Washercap Mini Fixation System 4.5mm, Washercap Fixation System 10mm |
| Biopro, INC. | $51.92 | 2025 | Hemi Toe |
| Kerecis Limited | $45.02 | 2022 | |
| Sanara Medtech INC. | $44.50 | 2025 | Celleraterx |
| Davol INC. | $38.33 | 2022 | |
| Next Science LLC | $34.62 | 2024 | Surgx, Blastx, Xperience |
| Axogen | $33.08 | 2019 | |
| Globus Medical, INC. | $30.99 | 2023 | Ankle Fracture System |
| Urgo Medical North America, LLC | $30.62 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Alpha Orthopedic Systems | $29.77 | 2021 | |
| Abyrx, INC | $25.05 | 2019 | |
| Conmed Corporation | $18.99 | 2025 | Visiclear |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$46,878.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Giza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.